Latest revenue
$96.0K
as of 2026-03-31
Latest net income
$-2.5M
as of 2026-03-31
Net margin
-2555.2%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $49.2M
- Enterprise value
- $49.2M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $4.22
- 52-wk low
- $0.31
- Beta
- —
- Shares out
- 54.4M
5-year trend
What this company does
Item 1. Business Company Overview OneMedNet is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (“iRWDTM”). OneMedNet’s innovative solutions connect healthcare providers and patients satisfying a crucial need within the life sciences field offering direct access to clinical images and the associated contextual patient record. OneMedNet’s innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet’s life science partners case selection protocols and paves the way for Real World…
AI summary unavailable — showing raw filing excerpt
Generated from ONMD's filing dated 2026-03-30
Key risks
Item 1A. Risk Factors An investment in our securities involves a high degree of risk. The risks and uncertainties we have described in this Annual Report are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business, financial condition, and results of operations. We may not be successful in preventing the material adverse effects that any of the following risks and uncertainties may cause. You should carefully consider the following risks, as well as the other information contained in this Annual Report, including our historical financial statements and related notes included elsewhere in this…
AI summary unavailable — showing raw filing excerpt
Generated from ONMD's filing dated 2026-03-30
Profitability
Gross margin
-37.0%
15.3%Operating margin
-711.3%
52.4%Net margin
-206.1%
86.9%Return on equity
94.5%
48.8%Return on assets
-130.2%
52.1%Leverage
Debt / equity
-1.73×
39.9%Long-term debt / equity
-0.07×
74.3%Debt / assets
237.8%
55.0%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $96.0K | -29.9% | $-2.5M | -29.0% | -2555.2% |
Q4 2025 2025-12-31 | $1.1M | +858.1% | $-2.3M | +2.3% | -206.8% |
Q3 2025 2025-09-30 | $-54.0K | -205.9% | $339.0K | +116.5% | — |
Q2 2025 2025-06-30 | $155.0K | -31.7% | $1.1M | +130.1% | 696.8% |
Q1 2025 2025-03-31 | $137.0K | -44.8% | $-1.9M | +9.8% | -1388.3% |
Q4 2024 2024-12-31 | $117.0K | — | $-2.4M | — | -2028.2% |
Q3 2024 2024-09-30 | $51.0K | -84.4% | $-2.1M | -21.7% | -4035.3% |
Q2 2024 2024-06-30 | $227.0K | +31.2% | $-3.6M | -69481.2% | -1581.1% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Commercial Physical & Biological Research · SIC 8731
Your notes
Keep private notes on ONMD — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$3.8M
Insider selling
$218.6K
Net activity
+$3.5M
Distinct insiders
4
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ONMD
Institutional value
$8.5M
Total shares held
10.0M
Distinct holders
12
-11 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | EXENCIAL WEALTH ADVISORS, LLC | 8.4M | $7.1M | +4.7M (+129.8%) | Added |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | $948.2K | — | New |
| 3 | VANGUARD FIDUCIARY TRUST CO | 136.6K | $116.1K | — | New |
| 4 | CITIGROUP INC | 135.4K | $115.1K | — | New |
| 5 | JANE STREET GROUP, LLC | 111.7K | $95.0K | +3.6K (+3.3%) | Added |
| 6 | BlackRock, Inc. | 70.1K | $59.6K | +0 (+0.0%) | No change |
| 7 | Ashton Thomas Private Wealth, LLC | 26.6K | $22.6K | +3.5K (+15.4%) | Added |
| 8 | PNC Financial Services Group, Inc. | 17.3K | $14.7K | +0 (+0.0%) | No change |
| 9 | UBS Group AG | 16.2K | $13.8K | -97.5K (-85.7%) | Trimmed |
| 10 | Procyon Advisors, LLC | 13.8K | $11.7K | +0 (+0.0%) | No change |
| 11 | OpenArc Corporate Advisory, LLC | 11.3K | $9.6K | +0 (+0.0%) | No change |
| 12 | SBI Securities Co., Ltd. | 157 | $133 | +14 (+9.8%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once ONMD's latest filing finishes processing.